{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:22:57Z","timestamp":1790396577890,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Wolman disease is a rare disease caused by the absence of functional liposomal acid lipase due to mutations in\n                      <jats:italic>LIPA<\/jats:italic>\n                      gene. It presents with organomegaly, malabsorption, and adrenal calcifications. The presentations can resemble hemophagocytic lymphohistiocytosis, the life threatening hyperinflammatory disorder. Since the disease is very rare, clinicians might not think of it when a patient presents with hemophagocytic lymphohistiocytosis, and the opportunity to treat it properly can be lost, thus leading to demise of the child.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      We present a 4.5-month-old Caucasian boy with fever, icterus, and hepatosplenomegaly who was treated according to presumed hemophagocytic lymphohistiocytosis disease. Wolman disease was diagnosed after the death of the child. There are some case reports in the literature presenting patients with Wolman disease primarily diagnosed as hemophagocytic lymphohistiocytosis, which we discuss in this review. The genetic analysis revealed after his demise was compatible with Wolman disease, introducing a novel mutation in\n                      <jats:italic>LIPA<\/jats:italic>\n                      gene: exon 4: NM_001127605: c. G353A (p.G118D), which converts the glycine amino acid to aspartic acid.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Considering the similarities in presentation of Wolman disease and hemophagocytic lymphohistiocytosis, the patient\u2019s life can be saved if special attention is paid to presenting features of a patient with suspected hemophagocytic lymphohistiocytosis, that is special attention to symptoms, findings on physical exams, laboratory values, and radiologic findings, and the proper treatment is urgently initiated. Reporting the novel mutations of Wolman disease can help geneticists interpret the results of their patients\u2019 genetic studies appropriately, leading to correct diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-023-04116-4","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T20:02:09Z","timestamp":1693252929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Wolman disease presenting with hemophagocytic lymphohistiocytosis syndrome and a novel LIPA gene variant: a case report and review of the\u00a0literature\u00a0"],"prefix":"10.1186","volume":"17","author":[{"given":"Kosar","family":"Asna Ashari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Azari-Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahrooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4648-3573","authenticated-orcid":false,"given":"Vahid","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"5","key":"4116_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12098-016-2037-y","volume":"83","author":"M Madkaikar","year":"2016","unstructured":"Madkaikar M, Shabrish S, Desai M. Current updates on classification, diagnosis and treatment of hemophagocytic lymphohistiocytosis (HLH). Indian J Pediatr. 2016;83(5):434\u201343.","journal-title":"Indian J Pediatr"},{"issue":"8","key":"4116_CR2","first-page":"686","volume":"15","author":"JR Zhang","year":"2013","unstructured":"Zhang JR, Liang XL, Jin R, Lu G. HLH-2004 protocol: diagnostic and therapeutic guidelines for childhood hemophagocytic lymphohistiocytosis. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15(8):686\u20138.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"10","key":"4116_CR3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00431-014-2338-y","volume":"173","author":"R Taurisano","year":"2014","unstructured":"Taurisano R, Maiorana A, De Benedetti F, Dionisi-Vici C, Boldrini R, Deodato F. Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation. Eur J Pediatr. 2014;173(10):1391\u20134.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"4116_CR4","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.clinre.2018.03.012","volume":"42","author":"E Santos Silva","year":"2018","unstructured":"Santos Silva E, Klaudel-Dreszler M, Bakula A, Oliva T, Sousa T, Fernandes PC, Tylki-Szymanska A, Kamenets E, Martins E, Socha P. Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: two infants treated with sebelipase alfa. Clin Res Hepatol Gastroenterol. 2018;42(5):e77\u201382.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"17","key":"4116_CR5","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","volume":"118","author":"H Trottestam","year":"2011","unstructured":"Trottestam H, Horne A, Aric\u00f2 M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, et\u00a0al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577\u201384.","journal-title":"Blood"},{"key":"4116_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/2213988501711010001","volume":"11","author":"F Aguisanda","year":"2017","unstructured":"Aguisanda F, Thorne N, Zheng W. Targeting Wolman disease and cholesteryl ester storage disease: disease pathogenesis and therapeutic development. Curr Chem Genom Transl Med. 2017;11:1\u201318.","journal-title":"Curr Chem Genom Transl Med"},{"key":"4116_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2147\/DDDT.S149264","volume":"14","author":"GM Pastores","year":"2020","unstructured":"Pastores GM, Hughes DA. Lysosomal acid lipase deficiency: therapeutic options. Drug Des Devel Ther. 2020;14:591\u2013601.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"4116_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139.","journal-title":"Nat Methods"},{"key":"4116_CR9","doi-asserted-by":"crossref","unstructured":"Choi Y. A fast computation of pairwise sequence alignment scores between a protein and a set of single-locus variants of another protein. In: Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine: 2012; 2012: 414\u2013417.","DOI":"10.1145\/2382936.2382989"},{"key":"4116_CR10","doi-asserted-by":"publisher","first-page":"e4668","DOI":"10.1371\/journal.pone.0046688","volume":"7","author":"Y Choi","year":"2012","unstructured":"Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS ONE. 2012;7:e4668.","journal-title":"PLoS ONE"},{"issue":"6","key":"4116_CR11","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1210\/jc.2004-0016","volume":"90","author":"R Perry","year":"2005","unstructured":"Perry R, Kecha O, Paquette J, Huot C, Van Vliet G, Deal C. Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab. 2005;90(6):3243\u201350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4116_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"4116_CR13","first-page":"264","volume":"34","author":"AK Yava\u015f","year":"2017","unstructured":"Yava\u015f AK, Orhaner B, Gen\u00e7 P, K\u0131l\u0131\u00e7 N, Erdo\u011fan H, \u00d6zdemir \u00d6, Ekici A. Secondary hemophagocytic lymphohistiocytosis in an infant with Wolman disease. Turk J Hematol. 2017;34(3):264.","journal-title":"Turk J Hematol"},{"issue":"3","key":"4116_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejmhg.2015.08.005","volume":"17","author":"S Elsayed","year":"2016","unstructured":"Elsayed S, Elsobky E, Tantawy A, Ragab E, Gil M, Lambert N, de Saint BG. Wolman disease in patients with familial hemophagocytic lymphohistiocytosis (FHL) negative mutations. Egypt J Med Human Genet. 2016;17(3):277\u201380.","journal-title":"Egypt J Med Human Genet"},{"issue":"3","key":"4116_CR15","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1097\/MPH.0000000000001192","volume":"41","author":"F Tinsa","year":"2019","unstructured":"Tinsa F, Ben Romdhane M, Boudabous H, Bel Hadj I, Brini I, Tebib N, Louati H, Bekri S, Boussetta K. A novel mutation c. 153 C> A in a Tunisian girl with Wolman disease and unusual presentation: hemophagocytic lymphohistiocytosis. J Pediatric Hematol\/Oncol. 2019;41(3):e193\u20136.","journal-title":"J Pediatric Hematol\/Oncol"},{"issue":"6","key":"4116_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3109\/08880018.2014.920942","volume":"31","author":"F Rabah","year":"2014","unstructured":"Rabah F, Al-Hashmi N, Beshlawi I. Wolman\u2019s disease with secondary hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol. 2014;31(6):576\u20138.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"4116_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12887-021-02541-2","volume":"21","author":"F Alabbas","year":"2021","unstructured":"Alabbas F, Elyamany G, Alanzi T, Ali TB, Albatniji F, Alfaraidi H. Wolman\u2019s disease presenting with secondary hemophagocytic lymphohistiocytosis: a case report from Saudi Arabia and literature review. BMC Pediatr. 2021;21(1):72.","journal-title":"BMC Pediatr"},{"key":"4116_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jped.2021.03.003","volume":"98","author":"CR Witeck","year":"2021","unstructured":"Witeck CR, Schmitz AC, de Oliveira JMD, Porporatti AL, De Luca Canto G, Pires MMS. Lysosomal acid lipase deficiency in pediatric patients: a scoping review. Jornal de Pediatria. 2021;98:4.","journal-title":"Jornal de Pediatria"},{"issue":"3","key":"4116_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ymgme.2011.12.008","volume":"105","author":"T Fasano","year":"2012","unstructured":"Fasano T, Pisciotta L, Bocchi L, Guardamagna O, Assandro P, Rabacchi C, Zanoni P, Filocamo M, Bertolini S, Calandra S. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. Mol Genet Metab. 2012;105(3):450\u20136.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"4116_CR20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/jclinpath-2012-201302","volume":"66","author":"T Reynolds","year":"2013","unstructured":"Reynolds T. Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis. J Clin Pathol. 2013;66(11):918\u201323.","journal-title":"J Clin Pathol"},{"key":"4116_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/1471-2105-11-548","volume":"11","author":"H Venselaar","year":"2010","unstructured":"Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinf. 2010;11:548.","journal-title":"BMC Bioinf"},{"key":"4116_CR22","doi-asserted-by":"crossref","unstructured":"Mustafa MI, Osman EA, Abdelmoneiom AH, Hassn DM, Yousif HM, Mahgoub IK, Badawi RM, Albushra KA, Abdelhameed TA, Hassan MA. Comprehensive in silico Analysis of IKBKAP gene that could potentially cause Familial dysautonomia. bioRxiv 2018:436071.","DOI":"10.1101\/436071"},{"issue":"7","key":"4116_CR23","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1096\/fasebj.5.7.2010058","volume":"5","author":"H Kuivaniemi","year":"1991","unstructured":"Kuivaniemi H, Tromp G, Prockop DJ. Mutations in collagen genes: causes of rare and some common diseases in humans. FASEB J. 1991;5(7):2052\u201360.","journal-title":"FASEB J"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04116-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:40:39Z","timestamp":1700358039000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04116-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4116"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04116-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained the consent of our patient\u2019s parents to participate in our case report. It should be noted that the results of the genetic study were available after the patient\u2019s demise, and we did not intend to report the case before that. This being said, our research did not have any influence on the course of the treatment. The study adhered to the tenets of Helsinki Declaration, and the ethical committee of our institution, Tehran University of Medical Sciences (TUMS). We used no experimental protocol, and the article was written after the patient\u2019s demise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}